These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 12451999

  • 1. [Expression and clinical significance of p53 and c-erbB2 in geriatric women with cervical carcinoma].
    Huang YW, Li MD, Wu QL, Liu FY.
    Ai Zheng; 2002 Mar; 21(3):297-300. PubMed ID: 12451999
    [Abstract] [Full Text] [Related]

  • 2. [Relationship between expressions of p53, c-erbB2 genes, proliferating cell nuclear antigen and prognosis of patients with ovarian epithelial carcinoma].
    Li JD, Li MD, Li YF, Huang X, Liu JH, Liu FY, Zhang CQ.
    Ai Zheng; 2002 Mar; 21(3):292-6. PubMed ID: 12451998
    [Abstract] [Full Text] [Related]

  • 3. [Expression of P53, P63, and C-erbB-2 in endometrioid adenocarcinoma and their clinicopathological significance].
    Hu WF, Liu MQ, Zhao Q.
    Ai Zheng; 2004 Sep; 23(9):1021-5. PubMed ID: 15363194
    [Abstract] [Full Text] [Related]

  • 4. The possible role of p53 and bcl-2 expression in cervical carcinomas and their premalignant lesions.
    Dimitrakakis C, Kymionis G, Diakomanolis E, Papaspyrou I, Rodolakis A, Arzimanoglou I, Leandros E, Michalas S.
    Gynecol Oncol; 2000 Apr; 77(1):129-36. PubMed ID: 10739702
    [Abstract] [Full Text] [Related]

  • 5. p53 and p21 expression in precancerous lesions and carcinomas of the uterine cervix: overexpression of p53 predicts poor disease outcome.
    Huang LW, Chou YY, Chao SL, Chen TJ, Lee TT.
    Gynecol Oncol; 2001 Nov; 83(2):348-54. PubMed ID: 11606096
    [Abstract] [Full Text] [Related]

  • 6. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.
    BMC Cancer; 2007 Apr 12; 7():63. PubMed ID: 17430582
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [A study on C-erbB2, nm23 and p53 expressions in epithelial ovarian cancer and their clinical significance].
    Liu L, Yang K.
    Zhonghua Fu Chan Ke Za Zhi; 1999 Feb 12; 34(2):101-4. PubMed ID: 11263193
    [Abstract] [Full Text] [Related]

  • 9. [Immunohistochemical study on the expression of c-erbB2 oncoprotein in breast tumors].
    Zhang Z, Xu G, Liu S.
    Zhonghua Zhong Liu Za Zhi; 1997 Jul 12; 19(4):287-9. PubMed ID: 11038761
    [Abstract] [Full Text] [Related]

  • 10. Tumor histology and stage but not p53, Her2-neu or cathepsin-D expression are independent prognostic factors in breast cancer patients.
    Korkolis DP, Tsoli E, Fouskakis D, Yiotis J, Koullias GJ, Giannopoulos D, Papalambros E, Nikiteas NI, Spiliopoulou CA, Patsouris E, Asimacopoulos P, Gorgoulis VG.
    Anticancer Res; 2004 Jul 12; 24(3b):2061-8. PubMed ID: 15274401
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Manganese superoxide dismutase expression correlates with p53 status and local recurrence of cervical carcinoma treated with radiation therapy.
    Nakano T, Oka K, Taniguchi N.
    Cancer Res; 1996 Jun 15; 56(12):2771-5. PubMed ID: 8665512
    [Abstract] [Full Text] [Related]

  • 13. [Relationship of oncogene C-erbB2 expression to ER, PR and PS2 in breast cancer and its prognostic significance].
    Yang JQ, Chen L, Xing TY.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 May 15; 35(3):334-6, 357. PubMed ID: 15181828
    [Abstract] [Full Text] [Related]

  • 14. The significance of c-erbB-2 overexpression and p53 expression in patients with axillary lymph node--negative breast cancer: a tissue microarray study.
    Ko SS, Na YS, Yoon CS, Park JY, Kim HS, Hur MH, Lee HK, Chun YK, Kang SS, Park BW, Lee JH.
    Int J Surg Pathol; 2007 Apr 15; 15(2):98-109. PubMed ID: 17478762
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.
    Suthipintawong C, Wejaranayang C, Vipupinyo C.
    J Med Assoc Thai; 2008 Dec 15; 91(12):1779-84. PubMed ID: 19133508
    [Abstract] [Full Text] [Related]

  • 17. Prognostic significance of Bax, Bcl-2, and p53 expressions in cervical squamous cell carcinoma treated by radiotherapy.
    Wootipoom V, Lekhyananda N, Phungrassami T, Boonyaphiphat P, Thongsuksai P.
    Gynecol Oncol; 2004 Sep 15; 94(3):636-42. PubMed ID: 15350352
    [Abstract] [Full Text] [Related]

  • 18. Protein expression and gene copy number analysis of topoisomerase 2alpha, HER2 and P53 in minimally invasive urothelial carcinoma of the urinary bladder--a multitissue array study with prognostic implications.
    Krüger S, Lange I, Kausch I, Feller AC.
    Anticancer Res; 2005 Sep 15; 25(1A):263-71. PubMed ID: 15816547
    [Abstract] [Full Text] [Related]

  • 19. Immunohistochemical study of microvessel density, CD44 (standard form), p53 protein and c-erbB2 in gallbladder carcinoma.
    Kalekou H, Miliaras D.
    J Gastroenterol Hepatol; 2004 Jul 15; 19(7):812-8. PubMed ID: 15209630
    [Abstract] [Full Text] [Related]

  • 20. Predictors of outcome in small cell carcinoma of the cervix--a case series.
    Straughn JM, Richter HE, Conner MG, Meleth S, Barnes MN.
    Gynecol Oncol; 2001 Nov 15; 83(2):216-20. PubMed ID: 11606074
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.